Trials / Unknown
UnknownNCT01410370
Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases
Phase II Study of Continuous Endostar Infusion Combined With Radiotherapy for the Treatment of Patients With Brain Metastases
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the clinical efficacy and safety of continuous Endostar infusion combined with radiotherapy for treatment of brain metastases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 6MV-X ray | 3Gy/time, 5 times/week, a total of 10 times |
| DRUG | Endostar | 7.5mg/m2/d, continuous infusion, in parallel with radiotherapy |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2011-08-05
- Last updated
- 2013-04-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01410370. Inclusion in this directory is not an endorsement.